The Role of IL-17 Signaling in Regulation of the Liver–Brain Axis and Intestinal Permeability in Alcoholic Liver Disease
Current Pathobiology Reports · 2016-03 · 4 (1) · 27-35
DOI: 10.1007/s40139-016-0097-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Pathobiology Reports, online erschienen am 19.02.2016. Verfasst von Hsiao-Yen Ma und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, UC San Diego, La Jolla, CA; Department of Surgery, UC San Diego, La Jolla, CA. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, NINDS NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Alcoholic liver disease (ALD) progresses from a normal liver, to steatosis, steatohepatitis, fibrosis and hepatocellular carcinoma (HCC). Despite intensive studies, the pathogenesis of ALD is poorly understood, in part due to a lack of suitable animal models which mimic the stages of ALD progression. Furthermore, the role of IL-17 in ALD has not been evaluated. We and others have recently demonstrated that IL-17 signaling plays a critical role in development of liver fibrosis and cancer. Here we summarize the most recent evidence supporting the role of IL-17 in ALD. As a result of a collaborative effort of Drs. Karin, Gao, Tsukamoto and Kisseleva, we developed several improved models of ALD in mice: 1) chronic-plus-binge model that mimics early stages of steatohepatitis, 2) intragastric ethanol feeding model that mimics alcoholic steatohepatitis and fibrosis, and 3) diethylnitrosamine (DEN)+alcohol model that mimics alcoholic liver cancer. These models might provide new insights into the mechanism of IL-17 signaling in ALD and help identify novel therapeutic targets.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, UC San Diego, La Jolla, CA; Department of Surgery, UC San Diego, La Jolla, CA.
- Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National, Institutes of Health, Bethesda, Maryland.
- Department of Pharmacology, UC San Diego, La Jolla, CA.
- Southern California Research Center for ALPD & Cirrhosis Department of Pathology Keck School of Medicine of USC, University of Southern California, and Department of Veterans Affairs Great Los Angeles Healthcare System,…
- Department of Psychiatry, UC San Diego, La Jolla, CA; Stein Institute for Research on Aging, UC San Diego, La Jolla, CA.
- Department of Psychiatry, UC San Diego, La Jolla, CA.
Förderung
- NIAAA NIH HHS
- NINDS NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
Zitieren
APA
Ma, H. Y., Xu, J., Liu, X., Zhu, Y., Gao, B., Karin, M., Tsukamoto, H., Jeste, D. V., Grant, I., Roberts, A. J., Contet, C., Geoffroy, C., Zheng, B., Brenner, D., & Kisseleva, T. (2016). The Role of IL-17 Signaling in Regulation of the Liver–Brain Axis and Intestinal Permeability in Alcoholic Liver Disease. Current Pathobiology Reports, 4(1), 27-35. https://doi.org/10.1007/s40139-016-0097-3
Vancouver
Ma HY, Xu J, Liu X, Zhu Y, Gao B, Karin M, et al. The Role of IL-17 Signaling in Regulation of the Liver–Brain Axis and Intestinal Permeability in Alcoholic Liver Disease. Current Pathobiology Reports. 2016;4(1):27-35. doi:10.1007/s40139-016-0097-3
BibTeX
@article{Ma2016,
author = {Ma, Hsiao-Yen and Xu, Jun and Liu, Xiao and Zhu, Yunheng and Gao, Bin and Karin, Michael and Tsukamoto, Hidekazu and Jeste, Dilip V and Grant, Igor and Roberts, Amanda J and Contet, Candice and Geoffroy, Cedric and Zheng, Binhai and Brenner, David and Kisseleva, Tatiana},
title = {The Role of IL-17 Signaling in Regulation of the Liver–Brain Axis and Intestinal Permeability in Alcoholic Liver Disease},
journal = {Current Pathobiology Reports},
year = {2016},
volume = {4},
number = {1},
pages = {27--35},
doi = {10.1007/s40139-016-0097-3}
}
EUVIMED